1. A multicentre, phase II trial of ofatumumab monotherapy in relapsed/progressive diffuse large B‐cell lymphoma. (23rd August 2013) Authors: Coiffier, Bertrand; Radford, John; Bosly, André; Martinelli, Giovanni; Barca, Gabriela; Davies, Andrew; Decaudin, Didier; Gallop‐Evans, Eve; Padmanabhan‐Iyer, Swaminathan; Van, Koen; Wu, Ka Lung; Gupta, Ira V.; Lin, Thomas S.; Goldstein, Nancy; Jewell, Roxanne C.; Winter, Paul; Lisby, Steen Journal: British journal of haematology Issue: Volume 163:Number 3(2013:Nov.) Page Start: 334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Associations of ofatumumab exposure and treatment outcomes in patients with untreated CLL receiving chemoimmunotherapy. Issue 2 (1st February 2017) Authors: Jewell, Roxanne C.; Kipps, Thomas J.; Dürig, Jan; Griskevicius, Laimonas; Stilgenbauer, Stephan; Smolej, Lukáš; Mayer, Jiří; Hess, Georg; Hernandez-Ilizaliturri, Francisco J.; Padmanabhan-Iyer, Swaminathan; Fang, Lei; Goldstein, Nancy; Gorczyca, Michele; Gupta, Ira; Lisby, Steen; Wierda, William G. Journal: Leukemia & lymphoma Issue: Volume 58:Issue 2(2017) Page Start: 348 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial. Issue 9980 (9th May 2015) Authors: Hillmen, Peter; Robak, Tadeusz; Janssens, Ann; Babu, K Govind; Kloczko, Janusz; Grosicki, Sebastian; Doubek, Michael; Panagiotidis, Panagiotis; Kimby, Eva; Schuh, Anna; Pettitt, Andrew R; Boyd, Thomas; Montillo, Marco; Gupta, Ira V; Wright, Oliver; Dixon, Iestyn; Carey, Jodi L; Chang, Chai-Ni; Li... Journal: Lancet Issue: Volume 385:Issue 9980(2015) Page Start: 1873 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial. Issue 10027 (9th April 2016) Authors: Lonial, Sagar; Weiss, Brendan M; Usmani, Saad Z; Singhal, Seema; Chari, Ajai; Bahlis, Nizar J; Belch, Andrew; Krishnan, Amrita; Vescio, Robert A; Mateos, Maria Victoria; Mazumder, Amitabha; Orlowski, Robert Z; Sutherland, Heather J; Bladé, Joan; Scott, Emma C; Oriol, Albert; Berdeja, Jesus; Ghari... Journal: Lancet Issue: Volume 387:Issue 10027(2016) Page Start: 1551 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Health-related quality of life and patient-reported outcomes of ofatumumab plus fludarabine and cyclophosphamide versus fludarabine and cyclophosphamide in the COMPLEMENT 2 trial of patients with relapsed CLL. Issue 7 (3rd July 2017) Authors: Robak, Tadeusz; Warzocha, Krzysztof; Govind Babu, K.; Kulyaba, Yaroslav; Kuliczkowski, Kazimierz; Abdulkadyrov, Kudrat; Loscertales, Javier; Kryachok, Iryna; Kłoczko, Janusz; Rekhtman, Grygoriy; Homenda, Wojciech; Błoński, Jerzy Z.; McKeown, Astrid; Chang, Chai-Ni; Bal, Vasudha; Lisby, Steen; Gup... Journal: Leukemia & lymphoma Issue: Volume 58:Issue 7(2017) Page Start: 1598 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 study. Issue 13 (October 2015) Authors: van Oers, Marinus H J; Kuliczkowski, Kazimierz; Smolej, Lukáš; Petrini, Mario; Offner, Fritz; Grosicki, Sebastian; Levin, Mark-David; Gupta, Ira; Phillips, Jennifer; Williams, Vanessa; Manson, Stephanie; Lisby, Steen; Geisler, Christian Journal: Lancet oncology Issue: Volume 16:Issue 13(2015) Page Start: 1370 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Ofatumumab plus fludarabine and cyclophosphamide in relapsed chronic lymphocytic leukemia: results from the COMPLEMENT 2 trial. Issue 5 (4th May 2017) Authors: Robak, Tadeusz; Warzocha, Krzysztof; Govind Babu, K.; Kulyaba, Yaroslav; Kuliczkowski, Kazimierz; Abdulkadyrov, Kudrat; Loscertales, Javier; Kryachok, Iryna; Kłoczko, Janusz; Rekhtman, Grygoriy; Homenda, Wojciech; Błoński, Jerzy Z.; McKeown, Astrid; Gorczyca, Michele M.; Carey, Jodi L.; Chang, Ch... Journal: Leukemia & lymphoma Issue: Volume 58:Issue 5(2017) Page Start: 1084 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Ofatumumab retreatment and maintenance in fludarabine‐refractory chronic lymphocytic leukaemia patients. (30th March 2015) Authors: Österborg, Anders; Wierda, William G.; Mayer, Jiří; Hess, Georg; Hillmen, Peter; Schetelig, Johannes; Schuh, Anna; Smolej, Lukáš; Beck, Christian; Dreyfus, Brigitte; Hellman, Andrzej; Kozlowski, Piotr; Pfreundschuh, Michael; Rizzi, Rita; Spacek, Martin; Phillips, Jennifer L.; Gupta, Ira V.; Willi... Journal: British journal of haematology Issue: Volume 170:Number 1(2015:Jul.) Page Start: 40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Once-weekly ofatumumab in untreated or relapsed Waldenström's macroglobulinaemia: an open-label, single-arm, phase 2 study. Issue 1 (January 2017) Authors: Furman, Richard R; Eradat, Herbert A; DiRienzo, Christine G; Hofmeister, Craig C; Hayman, Suzanne R; Leonard, John P; Coleman, Morton; Advani, Ranjana; Chanan-Khan, Asher; Switzky, Julie; Liao, Qiming M; Shah, Damini; Jewell, Roxanne C; Lisby, Steen; Lin, Thomas S Journal: Lancet Issue: Volume 4:Issue 1(2017) Page Start: e24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase III, randomized study of ofatumumab versus physicians' choice of therapy and standard versus extended-length ofatumumab in patients with bulky fludarabine-refractory chronic lymphocytic leukemia. Issue 9 (1st September 2016) Authors: Österborg, Anders; Udvardy, Miklós; Zaritskey, Andrey; Andersson, Per-Ola; Grosicki, Sebastian; Mazur, Grzegorz; Kaplan, Polina; Steurer, Michael; Schuh, Anna; Montillo, Marco; Kryachok, Iryna; Middeke, Jan Moritz; Kulyaba, Yaroslav; Rekhtman, Grygoriy; Gorczyca, Michele; Daly, Siobhan; Chang, Ch... Journal: Leukemia & lymphoma Issue: Volume 57:Issue 9(2016:Sep.) Page Start: 2037 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗